Author

Johann Gout

REAL-LIFE EXPERIENCE OF PHARMACOTYPING AND RESPONSE PREDICTION USING PANCREATIC CANCER PATIENT-DERIVED ORGANOIDS
REAL-LIFE EXPERIENCE OF PHARMACOTYPING AND RESPONSE PREDICTION USING PANCREATIC CANCER PATIENT-DERIVED ORGANOIDS

Johann Gout  et al.

EXPLORING ROLES OF ATM-DELETION IN PANCREATIC CANCER VULNERABILITIES AND CANCER-ASSOCIATED FIBROBLAST/TUMOR CELL CROSSTALK
EXPLORING ROLES OF ATM-DELETION IN PANCREATIC CANCER VULNERABILITIES AND CANCER-ASSOCIATED FIBROBLAST/TUMOR CELL CROSSTALK

Johann Gout  et al.

PARP INHIBITOR RESISTANCE INDUCES MASSIVE GENOME ALTERATIONS RESPONSIBLE OF THE ACQUISITION OF MULTIDRUG RESISTANCE IN DNA DAMAGE REPAIR-DEFICIENT PANCREATIC CANCER
PARP INHIBITOR RESISTANCE INDUCES MASSIVE GENOME ALTERATIONS RESPONSIBLE OF THE ACQUISITION OF MULTIDRUG RESISTANCE IN DNA DAMAGE REPAIR-DEFICIENT PANCREATIC CANCER

Johann Gout  et al.

A NOVEL SYNERGISTIC THERAPY APPROACH TO TREAT DNA DAMAGE REPAIR DEFICIENT PANCREATIC CANCER
A NOVEL SYNERGISTIC THERAPY APPROACH TO TREAT DNA DAMAGE REPAIR DEFICIENT PANCREATIC CANCER

Johann Gout  et al.

A NOVEL SYNERGISTIC THERAPY APPROACH TO TREAT DNA DAMAGE REPAIR DEFICIENT PANCREATIC CANCER
A NOVEL SYNERGISTIC THERAPY APPROACH TO TREAT DNA DAMAGE REPAIR DEFICIENT PANCREATIC CANCER

Johann Gout

ATM AND P53 AUTONOMOUS ROLES DURING PANCREATIC CANCER TUMORIGENESIS
ATM AND P53 AUTONOMOUS ROLES DURING PANCREATIC CANCER TUMORIGENESIS

ATM AND P53 AUTONOMOUS ROLES DURING PANCREATIC CANCER TUMORIGENESIS
ATM AND P53 AUTONOMOUS ROLES DURING PANCREATIC CANCER TUMORIGENESIS

Johann Gout  et al.

THE TRANSCRIPTION FACTOR TBX3 FOSTERS REGENERATION FROM ACUTE PANCREATITIS AND SHOWS SWITCHING EXPRESSION PATTERNS IN THE EMBRYONIC PANCREAS
THE TRANSCRIPTION FACTOR TBX3 FOSTERS REGENERATION FROM ACUTE PANCREATITIS AND SHOWS SWITCHING EXPRESSION PATTERNS IN THE EMBRYONIC PANCREAS

Johann Gout  et al.

MAINTENANCE THERAPY FOR ATM-DEFICIENT PANCREATIC CANCER BY MULTIPLE DNA REPAIR PATHWAY INHIBITION AFTER PLATINUM-BASED CHEMOTHERAPY
MAINTENANCE THERAPY FOR ATM-DEFICIENT PANCREATIC CANCER BY MULTIPLE DNA REPAIR PATHWAY INHIBITION AFTER PLATINUM-BASED CHEMOTHERAPY

Johann Gout  et al.

RINT1 DOWNREGULATION DISRUPTS PANCREATIC DUCTAL ADENOCARCINOMA HOMEOSTASIS
RINT1 DOWNREGULATION DISRUPTS PANCREATIC DUCTAL ADENOCARCINOMA HOMEOSTASIS

Johann Gout  et al.

THE ROLE OF THE TRANSCRIPTION FACTOR TBX3 IN THE EMBRYONIC DEVELOPMENT OF THE MURINE PANCREAS AND REGENERATION OF ACUTE PANCREATITIS
THE ROLE OF THE TRANSCRIPTION FACTOR TBX3 IN THE EMBRYONIC DEVELOPMENT OF THE MURINE PANCREAS AND REGENERATION OF ACUTE PANCREATITIS

Johann Gout  et al.

PATIENT-DERIVED PANCREATIC CANCER ORGANOIDS AS A PERSONALIZED PRECLINICAL TOOL FOR DRUG RESPONSE PREDICTION
PATIENT-DERIVED PANCREATIC CANCER ORGANOIDS AS A PERSONALIZED PRECLINICAL TOOL FOR DRUG RESPONSE PREDICTION

Johann Gout  et al.

PRECLINICAL VALIDATION OF NOVEL GENOTYPE-SPECIFIC THERAPEUTIC CONCEPTS FOR ATM-DEFICIENT PANCREATIC CANCER
PRECLINICAL VALIDATION OF NOVEL GENOTYPE-SPECIFIC THERAPEUTIC CONCEPTS FOR ATM-DEFICIENT PANCREATIC CANCER

Johann Gout  et al.

FUNCTIONAL GENOMIC SCREENING DURING SOMATIC CELL REPROGRAMMING IDENTIFIES DKK3 AS A ROADBLOCK OF ORGAN REGENERATION
FUNCTIONAL GENOMIC SCREENING DURING SOMATIC CELL REPROGRAMMING IDENTIFIES DKK3 AS A ROADBLOCK OF ORGAN REGENERATION

Johann Gout  et al.

TBX3 SHOWS SWITCHING EXPRESSION PATTERNS IN THE EMBRYONIC PANCREAS AND FINE-TUNES REGENERATION FROM ACUTE PANCREATITIS
TBX3 SHOWS SWITCHING EXPRESSION PATTERNS IN THE EMBRYONIC PANCREAS AND FINE-TUNES REGENERATION FROM ACUTE PANCREATITIS

Johann Gout  et al.

EZH2, AN EPIGENETIC FACTOR INVOLVED IN ONCOGENIC PROPERTIES OF ATM DEFICIENT PDAC SUBTYPES?
EZH2, AN EPIGENETIC FACTOR INVOLVED IN ONCOGENIC PROPERTIES OF ATM DEFICIENT PDAC SUBTYPES?

Johann Gout  et al.

COMPARTMENT-SPECIFIC ROLE OF DKK3 IN THE DEVELOPMENT OF PANCREATIC DUCTAL ADENOCARCINOMA
COMPARTMENT-SPECIFIC ROLE OF DKK3 IN THE DEVELOPMENT OF PANCREATIC DUCTAL ADENOCARCINOMA

Johann Gout  et al.

LOSS OF ATM DRIVES NUTRIENT STRESS-INDUCED METABOLIC REPROGRAMMING SUPPORTING PANCREATIC CANCER AGGRESSIVENESS
LOSS OF ATM DRIVES NUTRIENT STRESS-INDUCED METABOLIC REPROGRAMMING SUPPORTING PANCREATIC CANCER AGGRESSIVENESS

Johann Gout  et al.

IS ATM DEFICIENCY PROVIDE A BENEFIT TO PANCREATIC TUMOR CELLS IN A METABOLIC STRESS CONTEXT?
IS ATM DEFICIENCY PROVIDE A BENEFIT TO PANCREATIC TUMOR CELLS IN A METABOLIC STRESS CONTEXT?

Johann Gout  et al.

ATM DEFICIENCY DRIVES METABOLIC REPROGRAMMING IN PANCREATIC CANCER CELLS
ATM DEFICIENCY DRIVES METABOLIC REPROGRAMMING IN PANCREATIC CANCER CELLS

Johann Gout  et al.

Item 1 - 20 / 25
1
2